Wasdell Group extends business into the US

We are delighted to announce that this year the Wasdell Group has recently established a presence within the United States, with a new US entity secured in Pennsylvania. The US presence comes as part of Wasdell’s latest step in extending our global reach to support our business activity and establish a local presence for our […]

Read more

Implications of Brexit on the FMD

With still so much uncertainty around Brexit and it’s impact on the pharmaceutical industry, our Managing Director, Daniel Tedham talks to CPHI online about the possible implications of a ‘no-deal’ Brexit and what Wasdell are doing in a bid to ensure seamless operations.                 Read the full article […]

Read more

Wasdell expand with appointment of new CEO

Wasdell are delighted to announce the appointment of our new C.E.O. Vincent Dunne who has joined us to further strengthen our service offerings to our customers and support the ongoing growth plans for the business. Read all about the Group’s new C.E.O. here: Wasdell Group appoints new CEO  

Read more

Predictions for 2019

With 2019 underway, Wasdell’s Managing Director Daniel Tedham weighs in with Pharma Manufacturing about the expectations for the next twelve months and what changes are to come. “As the demand for personalised medicines rises, smaller volume biotech products are therefore likely to be prevalent across 2019 as breakthroughs for rare and hard to treat conditions […]

Read more

Wasdell’s record growth

Our growth in recent years has allowed us to expand our service offerings within clinical development, manufacturing and packaging. It also brings opportunities to invest in our facilities and enabled us to build our first site outside of the UK. Read more about Wasdell’s growth here

Read more

DSCSA 1 month and counting..

Are you ready? At such a late stage, any company that is not close to validating their solution will have to look for third-party contract providers to outsource their serialization requirements to.” With less than a month to go until the DSCSA enforcement deadline Wasdell Manufacturing’s managing director Daniel Tedham talks to CPhI Online amongst […]

Read more

Future-proofing your serialisation solution

In order to tackle the growing problem of counterfeit medicines, the EU has introduced the European Falsified Medicines Directive due to come into force in February 2019. By this time, three quarters of the world’s prescription medicines will fall under track and trace legislation aimed at preserving supply chain integrity. However, many companies are anticipating […]

Read more

Wasdell launch own Fleet of Articulated Lorries

Wasdell are proud to announce this week that our articulated lorries are now ready to be used to provide even more control over the distribution of pharmaceutical products. Our three temperature controlled lorries will be used to deliver pharmaceutical products into Europe from now on. Martin Tedham, C.E.O is seen with Robert Buckland, MP and […]

Read more

Wasdell Group launch serialisation service

The Wasdell Group (Wasdell), a leading outsourcing partner to companies within the pharmaceutical, medical device and clinical trials industries, has launched its serialisation service ahead of the EU FMD and US DSCSA implementation deadlines. Following a £2.8 million investment into serialisation capabilities in 2016, the company will offer compliant products to all markets, including Europe […]

Read more

The Wasdell Group Launches Biodegradable Pots and Caps

The Wasdell Group is delighted to announce they have secured a deal to become the sole supplier of a new innovative biodegradable type of packaging for both bottles and caps into both Ireland and the UK. This is unique in itself with most plastics taking up to 400 years to break down, if at all. […]

Read more

1 2
top